Thromboembolic adverse events are preventable. In a large randomized controlled trial (RCT) of primary thromboprophylaxis with rivaroxaban 10 mg once daily (v placebo) in ambulatory patients with ...

Janux’s second clinical candidate, JANX008, is a TRACTr that targets EGFR and is being studied in a Phase 1 clinical trial for the treatment of multiple solid cancers including colorectal ...

A new study identifying 56 non-clinical risk factors associated with sudden cardiac arrest (SCA), spanning lifestyle, physical measures, psychosocial factors, socioeconomic status, and the local ...

Considering a migraine clinical trial? Learn about the types, benefits, risks, and eligibility, along with what questions you should ask to see if participating is right for you.

Treatment with sotagliflozin resulted in no increased risk and a reduction in hypoglycemia events, particularly in patients with blood glucose ≤55 mg/dL THE WOODLANDS, Texas, June 23, 2025 ...

Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis ...

Here's who the FDA says can get a new COVID-19 vaccine this fall amid a change in policy 02:33. The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates ...

Kidney failure risk and worsening kidney function were reduced by 16% and 21%, respectively. MACE risk was reduced by 13% in individuals with diabetes and 14% when SELECT was included in the analysis.